ZA845833B - Anti-viral compositions - Google Patents

Anti-viral compositions

Info

Publication number: ZA845833B
Authority: ZA; South Africa
Prior art keywords: viral compositions; viral; compositions; idoxuridine; vidarabine
Prior art date: 1983-07-27

Application number

ZA845833A

Other languages

English (en)

Inventor

David Frederick Horrobin

Original Assignee

Horrobin David F

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-07-27

Filing date

1984-07-27

Publication date

1985-03-27

1984-07-27 Application filed by Horrobin David F filed Critical Horrobin David F

1985-03-27 Publication of ZA845833B publication Critical patent/ZA845833B/xx

Links

230000000840 anti-viral effect Effects 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 abstract 1
OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 abstract 1
229960004150 aciclovir Drugs 0.000 abstract 1
MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 abstract 1
239000003443 antiviral agent Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
229960004716 idoxuridine Drugs 0.000 abstract 1
229910003002 lithium salt Inorganic materials 0.000 abstract 1
159000000002 lithium salts Chemical class 0.000 abstract 1
229960003636 vidarabine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

ZA845833A 1983-07-27 1984-07-27 Anti-viral compositions ZA845833B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB838320203A GB8320203D0 (en)	1983-07-27	1983-07-27	Anti-viral compositions

Publications (1)

Publication Number	Publication Date
ZA845833B true ZA845833B (en)	1985-03-27

Family

ID=10546347

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA845833A ZA845833B (en)	1983-07-27	1984-07-27	Anti-viral compositions

Country Status (9)

Country	Link
US (2)	US4886670A (de)
EP (1)	EP0135312B1 (de)
AT (1)	ATE48945T1 (de)
AU (1)	AU578031B2 (de)
CA (1)	CA1218931A (de)
DE (1)	DE3480828D1 (de)
GB (1)	GB8320203D0 (de)
HK (1)	HK127693A (de)
ZA (1)	ZA845833B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8706052D0 (en) *	1987-03-13	1987-04-15	Medical Research Int	Therapeutic compositions
DE3921062A1 (de) *	1989-06-23	1991-01-03	Lange Werner	Therapie und prophylaxe von infektionen mit retroviren mit 1-adamantanamin hydrochlorid (amantadin) allein oder in kombination mit anderen antiviralen substanzen
DE4014672A1 (de) *	1990-05-08	1991-11-14	Werner E G Prof Dr Mueller	Verwendung von adamantan-derivaten zur zytoprotektion von nicht-infizierten und virus-infizierten lymphozyten als auch anderen zelltypen
GB9023701D0 (en) *	1990-10-31	1990-12-12	Efamol Holdings	Medical treatment
WO1993010793A1 (fr) *	1991-12-03	1993-06-10	Jury Petrovich Vainberg	Agent antiviral
IL104283A (en) *	1992-12-30	1996-12-05	Agis Ind 1983 Ltd	Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
GB9304746D0 (en) *	1993-03-09	1993-04-28	Scotia Holdings Plc	Treatment of viral infections
EP0688222B1 (de) *	1993-03-12	1998-05-13	Keele University	Therapeutische zusammensetzungen die lithiumverbindungen und silika enthalten
FR2740341B1 (fr) *	1995-10-26	1997-12-19	Oreal	Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
FR2740335B1 (fr) *	1995-10-26	1997-12-19	Oreal	Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
FR2740342B1 (fr) *	1995-10-26	1997-12-19	Oreal	Utilisation de sel de lanthanide, de manganese, de lithium, d'etain, de zinc ou d'yttrium, de cobalt, de baryum, de strontium dans des compositions pharmaceutiques
US7767216B2 (en) *	1999-04-28	2010-08-03	The Regents Of The University Of Michigan	Antimicrobial compositions and methods of use
US8232320B2 (en) *	1999-04-28	2012-07-31	The Regents Of The University Of Michigan	Antimicrobial nanoemulsion compositions and methods
US7655252B2 (en) *	1999-04-28	2010-02-02	The Regents Of The University Of Michigan	Antimicrobial nanoemulsion compositions and methods
GB2355192A (en) *	1999-10-15	2001-04-18	Henderson Morley Res & Dev Ltd	Anti-viral treatment
DE60023180D1 (de) *	1999-12-30	2006-02-23	Henderson Morley Res & Dev Ltd	Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten
ES2164018B1 (es) *	2000-05-26	2003-06-16	Inst De Salud Carlos Iii	Empleo de una sal de litio en la elaboracion de un medicamento para el tratamiento de la infeccion causada por el virus respiratorio sincitial humano (vrdh)
WO2008137747A1 (en)	2007-05-02	2008-11-13	The Regents Of The University Of Michigan	Nanoemulsion therapeutic compositions and methods of using the same
US9974844B2 (en)	2008-11-17	2018-05-22	The Regents Of The University Of Michigan	Cancer vaccine compositions and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA849491A (en) *	1967-06-05	1970-08-18	Sherwin Lewis	Compositions containing lithium compounds
US3639625A (en) *	1967-07-13	1972-02-01	Lewis Sherwin	Compositions containing lithium succinate
FR2244485A1 (en) *	1973-08-06	1975-04-18	Aries Robert	Lithium dicarboxylic acid salts - in compositions for treatment of psychoses, esp. manic depression

1983
- 1983-07-27 GB GB838320203A patent/GB8320203D0/en active Pending
1984
- 1984-07-26 AU AU31204/84A patent/AU578031B2/en not_active Ceased
- 1984-07-26 DE DE8484305102T patent/DE3480828D1/de not_active Expired - Lifetime
- 1984-07-26 EP EP84305102A patent/EP0135312B1/de not_active Expired
- 1984-07-26 CA CA000459731A patent/CA1218931A/en not_active Expired
- 1984-07-26 AT AT84305102T patent/ATE48945T1/de not_active IP Right Cessation
- 1984-07-27 ZA ZA845833A patent/ZA845833B/xx unknown
1988
- 1988-02-23 US US07/159,128 patent/US4886670A/en not_active Expired - Fee Related
1989
- 1989-10-31 US US07/429,601 patent/US5080909A/en not_active Expired - Fee Related
1993
- 1993-11-18 HK HK1276/93A patent/HK127693A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
US4886670A (en)	1989-12-12
EP0135312A3 (en)	1986-12-30
CA1218931A (en)	1987-03-10
AU578031B2 (en)	1988-10-13
US5080909A (en)	1992-01-14
AU3120484A (en)	1985-09-12
EP0135312A2 (de)	1985-03-27
HK127693A (en)	1993-11-26
EP0135312B1 (de)	1989-12-27
GB8320203D0 (en)	1983-09-01
ATE48945T1 (de)	1990-01-15
DE3480828D1 (de)	1990-02-01

Publication	Publication Date	Title
ZA845833B (en)	1985-03-27	Anti-viral compositions
ES8500739A1 (es)	1984-11-01	Metodo de producir composiciones farmaceuticas de liberacion controlada y accion prolongada
MY102473A (en)	1992-06-30	Purine derivates and their pharmaceutical use
AU531882B2 (en)	1983-09-08	Antiviral composition
ES8503658A1 (es)	1985-04-01	Procedimiento para preparar fenoxipiridinas sulfuro-sustituidas teniendo actividad antiviral. desglose de la patente n 514.940.
AU4979879A (en)	1980-02-21	Antiviral composition
ZA839343B (en)	1985-07-31	Process for the production of dihydrocarbyl carbonates,their use as fuel additives and fuel compositions containing them
JPS5430102A (en)	1979-03-06	Carbon-carbon bond formation
JPS52285A (en)	1977-01-05	Preparation of n1 22tetrahydrofuryl*55fluorouracil
AU526125B2 (en)	1982-12-16	Antiviral compositions
DE3361270D1 (en)	1986-01-02	Amine oxide formulations
JPS5394007A (en)	1978-08-17	Preparation containing lysozyme or its acid salt
JPS542398A (en)	1979-01-09	Preparation of d-alpha-amino acid
JPS5742643A (en)	1982-03-10	6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraene-2-ol
JPS5226941A (en)	1977-02-28	Sole
JPS53139657A (en)	1978-12-06	Polyolefin resin composition
JPS5767578A (en)	1982-04-24	N-phthtalidy-5-fluorouracil derivative
GB2026031B (en)	1982-09-22	Circuit arrangement to increase the life of electrodes used as anodes
JPS53127834A (en)	1978-11-08	Anti-tumor preparation
JPS53113849A (en)	1978-10-04	Stabilizer composition
AU2114283A (en)	1984-05-17	Malonic acid derivatives as pesticides
JPS5435208A (en)	1979-03-15	Stabilization of prostaglandin and prostaglandin-ramily compound
JPS53118427A (en)	1978-10-16	Preparation of copper phthalocyanine in novel
JPS5388334A (en)	1978-08-03	Preparation of solid perfumery
JPS5439837A (en)	1979-03-27	Mimic breaker